BGEU vs. BIOG, BGS, AAIF, TAM, LWI, CTUK, JAGI, CTPE, HNE, and BIPS
Should you be buying Baillie Gifford European Growth Trust stock or one of its competitors? The main competitors of Baillie Gifford European Growth Trust include The Biotech Growth Trust (BIOG), Baillie Gifford Shin Nippon (BGS), abrdn Asian Income Fund (AAIF), Tatton Asset Management (TAM), Lowland Investment (LWI), CT UK Capital And Income Investment Trust (CTUK), JPMorgan Asia Growth & Income (JAGI), CT Private Equity Trust (CTPE), Henderson EuroTrust (HNE), and Invesco Bond Income Plus (BIPS). These companies are all part of the "asset management" industry.
The Biotech Growth Trust (LON:BIOG) and Baillie Gifford European Growth Trust (LON:BGEU) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, community ranking, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.
Baillie Gifford European Growth Trust has higher revenue and earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Baillie Gifford European Growth Trust, indicating that it is currently the more affordable of the two stocks.
The Biotech Growth Trust has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500. Comparatively, Baillie Gifford European Growth Trust has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.
In the previous week, Baillie Gifford European Growth Trust had 1 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 2 mentions for Baillie Gifford European Growth Trust and 1 mentions for The Biotech Growth Trust. The Biotech Growth Trust's average media sentiment score of 1.75 beat Baillie Gifford European Growth Trust's score of 0.76 indicating that Baillie Gifford European Growth Trust is being referred to more favorably in the news media.
Baillie Gifford European Growth Trust has a net margin of 117.62% compared to Baillie Gifford European Growth Trust's net margin of 0.00%. The Biotech Growth Trust's return on equity of 8.74% beat Baillie Gifford European Growth Trust's return on equity.
The Biotech Growth Trust received 82 more outperform votes than Baillie Gifford European Growth Trust when rated by MarketBeat users.
26.7% of The Biotech Growth Trust shares are held by institutional investors. Comparatively, 49.5% of Baillie Gifford European Growth Trust shares are held by institutional investors. 0.5% of The Biotech Growth Trust shares are held by company insiders. Comparatively, 2.5% of Baillie Gifford European Growth Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
Baillie Gifford European Growth Trust beats The Biotech Growth Trust on 13 of the 14 factors compared between the two stocks.
Get Baillie Gifford European Growth Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BGEU and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BGEU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Baillie Gifford European Growth Trust Competitors List
Related Companies and Tools
